Internal Medicine, Endocrinology, Diabetes, & Metabolism · Middleboro, MA
NPI
1447441472
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
8 Commerce Blvd
Middleboro, MA, 02346
Phone (508) 589-3775
Groups this clinician bills Medicare through
Medicare paid, 2024
$201K
7,830 services
Medicare patients, 2024
692
Average age 72
Drug cost, 2024
$3.7M
7,642 prescriptions
Company payments, 2025
$287
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by German Velasco was code J0897 (injection, denosumab, 1 mg), 5,280 times for 61 patients. In total German Velasco billed 7,830 services in 44 codes, and Medicare paid $201K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-12-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 5,280 | 61 | $20.38 | $108K |
| 99214 Office E&M - Established | Office | 694 | 469 | $87.78 | $61K |
| 36415 Venipuncture Blood Collection | Office | 350 | 307 | $8.65 | $3,028 |
| 84443 Clinical Chemistry | Office | 225 | 196 | $16.31 | $3,671 |
| 80053 Clinical Chemistry | Office | 175 | 172 | $10.23 | $1,791 |
| 96372 Injection Administration | Office | 157 | 71 | $9.08 | $1,426 |
| 83036 Blood Count | Office | 141 | 140 | $9.52 | $1,342 |
| 99213 Office E&M - Established | Office | 116 | 110 | $56.75 | $6,583 |
| 82607 Clinical Chemistry | Office | 104 | 104 | $14.64 | $1,522 |
| 84439 Clinical Chemistry | Office | 70 | 62 | $8.84 | $619 |
| 82043 Clinical Chemistry | Office | 70 | 70 | $5.66 | $396 |
| 82570 Clinical Chemistry | Office | 70 | 70 | $5.08 | $356 |
| 99204 Office E&M - New | Office | 55 | 55 | $105.54 | $5,805 |
| 80061 Clinical Chemistry | Office | 53 | 53 | $13.12 | $695 |
| 99212 Office E&M - Established | Office | 49 | 45 | $37.38 | $1,832 |
By year: 2022 $231K for 10,797 services; 2023 $256K for 11,782 services; 2024 $201K for 7,830 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 350 | 307 | $8.65 | $3,028 |
| 84443 Clinical Chemistry | 225 | 196 | $16.31 | $3,671 |
| 80053 Clinical Chemistry | 175 | 172 | $10.23 | $1,791 |
| 83036 Blood Count | 141 | 140 | $9.52 | $1,342 |
| 82607 Clinical Chemistry | 104 | 104 | $14.64 | $1,522 |
| 82043 Clinical Chemistry | 70 | 70 | $5.66 | $396 |
| 82570 Clinical Chemistry | 70 | 70 | $5.08 | $356 |
| 84439 Clinical Chemistry | 70 | 62 | $8.84 | $619 |
| 80061 Clinical Chemistry | 53 | 53 | $13.12 | $695 |
| 83970 Clinical Chemistry | 39 | 38 | $40.45 | $1,578 |
Medicare prescription drug claims, 2024
In 2024, the drug German Velasco prescribed most often to Medicare patients was Levothyroxine Sodium, with 997 prescriptions and refills. In total German Velasco wrote 7,642 Medicare prescriptions that cost $3.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 997 | 2,489 | 251 | $8,435 |
| Mounjaro Tirzepatide | 617 | 691 | 90 | $712K |
| Trulicity Dulaglutide | 503 | 715 | 89 | $680K |
| Jardiance Empagliflozin | 395 | 880 | 102 | $501K |
| Metformin Hcl Er Metformin Hcl | 331 | 948 | 107 | $5,159 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 262 | 473 | 74 | $23K |
| Pioglitazone Hcl Generic | 249 | 672 | 79 | $5,263 |
| Metformin Hcl Generic | 237 | 621 | 71 | $2,422 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 207 | 417 | 51 | $33K |
| Methimazole Generic | 203 | 539 | 63 | $2,307 |
| Glipizide Generic | 202 | 521 | 66 | $2,525 |
| Januvia Sitagliptin Phosphate | 183 | 409 | 50 | $217K |
| Ozempic Semaglutide | 159 | 275 | 38 | $252K |
| Glipizide Er Glipizide | 156 | 455 | 55 | $3,122 |
| Synthroid Levothyroxine Sodium | 148 | 387 | 41 | $13K |
Brand drugs: 3,909 claims; generic drugs: 3,093 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid German Velasco $287 ($287 in general payments such as food, travel and fees) from 3 companies. The largest payer was Amgen Inc. with $248.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.